Introduced here is an approach to further refining a set of locations that can serve as inputs to a machine learning algorithm. These locations may refer to unique molecular positions in a reference human genome and/or unique mutations thereof that are relevant in diagnosing cancer. A computing system can determine the diagnostic relevance of each location and then discard some of the less diagnostically relevant locations.
Legal claims defining the scope of protection, as filed with the USPTO.
6. The method of claim 5, wherein each score is representative of the metric produced for the corresponding location.
8. The method of claim 5, wherein the score is indicative of accuracy, precision, recall, sensitivity, specificity, or localization.
11. The method of claim 10, wherein said initiating and said causing are performed in response to said receiving.
13. The non-transitory medium of claim 12, wherein the genomic data is associated with a single patient that is known to have the given type of cancer.
14. The non-transitory medium of claim 12, wherein the genomic data is associated with multiple patients that are known to have the given type of cancer.
16. The non-transitory medium of claim 15, wherein the repository is associated with the National Cancer Institute, and wherein the genomic data is representative of a The Cancer Genome Atlas (TCGA) dataset.
18. The non-transitory medium of claim 17, wherein upon being applied to new genomic data associated with a patient whose health state is unknown, the model utilizes the locations included in the second list to determine whether any mutations are present that are indicative of the given type of cancer.
Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.
December 1, 2022
June 18, 2024
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.